NCT05408403

Brief Summary

This study evaluates the postoperative analgesic effects of transversalis fascia plane block and anterior quadratus lumborum block in patients having cesarean section under general anesthesia. General anesthesia will be performed to all patients for the surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 1, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 7, 2022

Completed
11 days until next milestone

Study Start

First participant enrolled

June 18, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 18, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 8, 2022

Completed
Last Updated

November 1, 2023

Status Verified

October 1, 2023

Enrollment Period

3 months

First QC Date

June 1, 2022

Last Update Submit

October 31, 2023

Conditions

Keywords

Regional AnesthesiaAcute and chronical painTransversalis Fascia Plane BlockQuadratus Lumborum BlocksCesarean Section

Outcome Measures

Primary Outcomes (1)

  • Opioid consumption in the first 24 hours after surgery

    Morphine consumption in the first 24 hours will be counted by IV patient controlled analgesia device (PCA). Patients will be able to request opioids via PCA device when the nrs score is above 4.

    Postoperative Day 1

Secondary Outcomes (2)

  • Post-operative acute pain

    Postoperative Day 1

  • The time of first opioid requirement

    Postoperative Day 1

Other Outcomes (2)

  • The incidences of post-operative nausea and vomiting (PONV)

    Postoperative Day 1

  • The incidence of side effects related to local anesthetics, opioid use and regional anesthesia technic

    Postoperative Day 1

Study Arms (2)

Transversalis Fascia Plane Block

ACTIVE COMPARATOR

Transversalis Fascia Plane Block (TFPB) will be performed the patients in Group A after the cesarean section surgery. Patient controlled analgesia device (PCA) is used for all the patients in the first 24 hours postoperatively

Other: Regional anesthesia TFPB

Quadratus Lumborum Block

ACTIVE COMPARATOR

Anterior Quadratus Lumborum Block ( Anterior QLB) will be performed the patients in Group B after the cesarean section surgery. Patient controlled analgesia device (PCA) is used for all the patients in the first 24 hours postoperatively

Other: Regional anesthesia QLB

Interventions

Transversalis Fascia Plane Block will be performed with 25 mL of 0.25% bupivacaine,after the end of cesarean surgery before extubation.

Also known as: Transversalis Fascia Plane Block
Transversalis Fascia Plane Block

Anterior Quadratus Lumborum Block will be performed with 25 mL of 0.25% bupivacaine, after the end of cesarean surgery before extubation.

Also known as: Anterior Quadratus Lumborum Block
Quadratus Lumborum Block

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant women planned for elective cesarean operation
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Being pregnant for at least 37 weeks
  • Planning an elective cesarean operation
  • Being between the ages of 18-45

You may not qualify if:

  • American Society of Anesthesiologists (ASA) 3-4 patients with comorbidities (Serious renal, cardiac, hepatic disease)
  • Being operated with spinal anesthesia
  • Obesity (\> 100 kg, BMI\> 35 kg / m2)
  • Contraindication of regional anesthesia (coagulopathy, abnormal international normalized ratio (INR), thrombocytopenia, infection at the injection site)
  • Hypersensitivity to local anesthetics or a history of allergy
  • Patients with a history of opioid use longer than four weeks
  • Patients with psychiatric disorders
  • Patients with anatomic deformity
  • Patients who do not want to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ondokuz Mayıs University Faculty of Medicine

Samsun, 55200, Turkey (Türkiye)

Location

MeSH Terms

Conditions

AgnosiaAcute PainChronic Pain

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsPain

Study Officials

  • Sezgin Bilgin

    Ondokuz Mayıs University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The anesthesia doctor who will perform the interfascial plane block (TFPB, anterior QLB) will be informed with a sealed envelope by an independent assistant outside the study, and the patient will not know which block is performed.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Randomization of the study will be done by a doctor who will not participate in patient follow-up with closed envelopes using computer-generated randomization codes.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

June 1, 2022

First Posted

June 7, 2022

Study Start

June 18, 2022

Primary Completion

September 18, 2022

Study Completion

November 8, 2022

Last Updated

November 1, 2023

Record last verified: 2023-10

Locations